
Dr Reddy’s arm signs exclusive licensing deal with Immutep for novel cancer therapy
Dr Reddy’s has entered an exclusive licensing agreement with Immutep to develop and commercialise its immunotherapy Eftilagimod Alfa across key global markets, with Immutep eligible…








